title: Oromandibular dystonia associated with SCA36.
authors: Ai
authors: A
authors: Miyashiro
authors: Katsunobu
authors: K
authors: Sugihara
authors: Toshitaka
authors: T
authors: Kawarai
authors: Ryosuke
authors: R
authors: Miyamoto
authors: Yuishin
authors: Y
authors: Izumi
authors: Hiroyuki
authors: H
authors: Morino
authors: Hirofumi
authors: H
authors: Maruyama
authors: Antonio
authors: A
authors: Orlacchio
authors: Hideshi
authors: H
authors: Kawakami
authors: Ryuji
authors: R
authors: Kaji
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D004421:Dystonia / Q000175:diagnosis / Q000188:drug therapy*; D020821:Dystonic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: C486600:NOP56 protein, human; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins; D019274:Botulinum Toxins, Type A